BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thankamony SP, Zhang Y. Exploratory biomarker assays: key assay parameters to evaluate in the face of evolving biomarker context-of-use. Bioanalysis 2019;11:2095-7. [DOI: 10.4155/bio-2019-0223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hays A, Amaravadi L, Fernandez-Metzler C, King L, Mathews J, Ni Y, Quadrini K, Tinder C, Vazvaei F, Zeng J. Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays? AAPS J 2022;24:65. [PMID: 35511303 DOI: 10.1208/s12248-022-00708-y] [Reference Citation Analysis]
2 Thankamony SP, Liu R, Peterson JE, Santockyte R, Olah T, Zhang Y. Calibrator material selection: a key criteria during biomarker assay method development. Bioanalysis 2021;13:787-96. [PMID: 33960820 DOI: 10.4155/bio-2020-0208] [Reference Citation Analysis]
3 Liu Y, Robinson R, Ung T, Spais C, Schreiber J, Lyons J, Husten J, Hallak H, Angeles T. Development of a Meso Scale Discovery ligand-binding assay for measurement of free (drug-unbound) target in nonhuman primate serum. Bioanalysis 2021;13:575-85. [PMID: 33749335 DOI: 10.4155/bio-2020-0307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chen J, Zheng N. Accelerating protein biomarker discovery and translation from proteomics research for clinical utility. Bioanalysis 2020;12:1469-81. [DOI: 10.4155/bio-2020-0198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]